CENTOGENE Appoints Ian Rentsch as Chief Commercial Officer 9-03-2023, 18:40

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000) 21-09-2024, 15:10

Work Truck Solutions Expands Supply Chain Support 10-03-2023, 01:17